Cycle for Cities Changing Diabetes touring seven UK cities in seven days to raise awareness of diabetes
Gatwick, 18 June 2019 – Novo Nordisk marked the third leg of an epic seven day ride across the UK by 120 cyclists as part of Cycle for Cities Changing Diabetes. Covering a total of 900km, the cyclists, comprising a core group of Novo Nordisk employees and ambassadors from Team Novo Nordisk, started in Leicester, calling at Manchester and Liverpool, before heading on to Birmingham, Bristol and Oxford, and ending at the Olympic Velopark in Stratford, London. Joining them along the route are healthcare professionals, people with diabetes and their family and friends, all with a united goal of raising awareness of diabetes and urging for more to be done to address this public health crisis.
Around 4.6 million people in the UK have diabetes[i] and NHS England estimates that the incidence rate of diabetes is increasing at a rate of 5% per year.[ii] Diabetes costs the NHS nearly £10 billion a year in direct costs, such as hospital admissions and treatment for the disease.[iii] Diabetes represents about 10% of the total NHS annual budget,3 with around 80% of the total diabetes spend being used for the treatment of complications like kidney failure, heart attacks, stroke, sight loss and amputations which are preventable.[iv]
Pinder Sahota, General Manager of Novo Nordisk UK commented: “A few years ago, the World Health Organisation highlighted diabetes and obesity as a slow-motion disaster, and Novo Nordisk recognises that as leaders in the diabetes space, we need to be leading the charge for change. Education about diabetes, especially from a young age, is vital to addressing this modern day crisis which is why we’re working with schools, paediatric hospitals and partners as part of our Cycle for Cities Changing Diabetes programme. We recognise we can’t do this alone and are so pleased to have great partners such as Leicester and Manchester, our UK Cities Changing Diabetes partners, as well as Diabetes UK and JDRF.”
The route for the cycle was planned around seven cities with high prevalence of diabetes. Alongside the cycle, Novo Nordisk is joining four morning school assemblies to talk about diabetes with 1,000 schoolchildren and teachers. Lunchtime Cities Changing Diabetes roundtables are being held in Liverpool, Birmingham, Bristol and Oxford, where
MPs, Mayors and city councils will meet to discuss projects that will improve the lives of people living with type 2 diabetes and in the future decrease the level of prevalence. These will be complemented by five lunchtime paediatric hospital visits and Talking About Diabetes (TAD) on Tour evening events where Novo Nordisk will get to engage with more than 500 healthcare professionals and patients in meaningful conversations around diabetes care. Capping the week off will be a family fun day at the London Olympic Park, in partnership with Ride Leicester, Diabetes UK, JDRF, Abbott and Dexcom.
[i] Diabetes UK: Facts and figures. (2017). Available at: http://www.diabetes.org.uk/professionals/position-statements-reports-statistics.
[ii] Public Accounts Committee: Management of adult diabetes service in the NHS: progress review (2016). Available at: http://www.publications.parliament.uk/pa/cm201516/cmselect/cmpubacc/563/563/pdf.
[iii] Diabetes UK. State of the Nation (2016). https://diabetes-resources-production.s3-eu-west-1.amazonaws.com/diabetes-storage/migration/pdf/Diabetes%2520UK%2520State%2520of%2520the%2520Nation%25202016.pdf
[iv] Diabetes UK. The cost of diabetes, 2014. Available at: https://www.diabetes.org.uk/resources-s3/2017-11/diabetes%20uk%20cost%20of%20diabetes%20report.pdf
- Mike Wood